外源性胰岛素自身免疫综合征合并线粒体糖尿病1例并文献复习OACSTPCD
Exogenous insulin autoimmune syndrome combined with mitochondrial diabetes mellitus:A case report and literature review
目的 报道 1例罕见的外源性胰岛素自身免疫综合征(exogenous insulin autoimmune syndrome,EIAS)合并线粒体糖尿病(mitochondrial diabetes mellitus,MDM)患者诊断、治疗的过程.方法 回顾南部战区总医院 2018年 12月收治的1例以EIAS合并MDM的发病过程、病史及相关辅助检查,总结分析其明确诊断、治疗的过程及特殊性.结果 本例患者30岁发病,糖尿病史 7年余,初期即出现耳鸣、听力下降,既往于外院曾应用多种胰岛素剂型,在治疗过程中曾出现低血糖,注射部位皮肤出现水泡,伴皮肤瘙痒,同时出现胰岛素水平显著升高,且与C肽结果"分离",胰岛素自身抗体(insulin autoantibody,IAA)阳性,考虑诊断为EIAS.治疗上停用胰岛素药物,予二甲双胍、DPP-Ⅳ抑制剂、阿卡波糖等口服降糖药物,胰岛素逐渐降至正常,血糖控制尚可;但患者糖尿病治疗过程中逐渐出现神经系统症状,头磁共振提示脑干和双侧小脑半球萎缩,查阅相关文献及结合患者病史,完善基因检测,最终明确患者为线粒体DNA MT-TL1基因A3243G突变所致的MDM.同时检测患者乳酸偏高,二甲双胍可能加重乳酸堆积,甚至诱发乳酸酸中毒,故停用二甲双胍降糖治疗,同时加强饮食和运动控制,患者定期规律门诊随访,血糖控制尚可.结论 本例患者初诊糖尿病后应用外源性胰岛素制剂诱发EIAS,但因疾病不断进展,出现无法解释的神经系统症状,完善基因检测明确为MDM.
Objective To report the process of diagnosis,treatment of a patient with Exogenous insulin autoimmune syndrome(EIAS)combined with mitochondrial diabetes mellitus(MDM).Methods The pathogenesis,medical history and relevant auxiliary examinations of a case admitted to the General Hospital of the Southern Theater of Operations of the People's Liberation Army(PLA)in December 2018 with EIAS combined with MDM were retrospectively analyzed,and the process of its definitive diagnosis,treatment,and special characteristics were summarized.Results The patient was 30 years old,with a history of diabetes mellitus for more than 7 years,tinnitus and hearing loss appeared at the beginning of the disease,and various insulin dosage forms had been applied in external hospitals.During the course of treatment,hypoglycemia appeared,blisters appeared on the skin at the injection site,accompanied by itching of the skin,there was a significant increase in the level of insulin,which was"detached"from the result of C-peptide.The test showed that the insulin autoantibody(IAA)was positive,then the diagnosis of EIAS was considered.The insulin injection was discontinued,and oral hypoglycemic drugs such as metformin,DPP-Ⅳinhibitors,and acarbose were given,then the insulin was gradually lowered to normal,and the blood glucose control was acceptable.However,neurological symptoms gradually appeared during the treatment,and the head MRI suggested that the brainstem and bilateral cerebellar hemispheres were atrophied.After reviewing the relevant literature and combining with the patient's medical history,the genetic test finally clarified that the patient's MDM was caused by the mutation of A3243G in MT-TL1 gene of mitochondrial DNA,and at the same time,the patient was detected to have high lactic acid,and metformin might aggravate the accumulation of lactic acid and even induce lactic acidosis,therefore,the patient stopped using metformin to lower glucose,and at the same time,the patient strengthened the control of diet and exercise.The patient was followed up regularly in outpatient clinic,and his blood glucose control was fair.Conclusion In this case,EIAS is induced by exogenous insulin preparation after the initial diagnosis of diabetes mellitus,but due to the continuous progression of the disease,unexplained neurological symptoms appear,and MDM is clearly identified by genetic testing.
蒋雪松;李佳
南部战区总医院内分泌科,广东广州 510010
临床医学
糖尿病外源性胰岛素自身免疫综合征胰岛素自身抗体线粒体基因突变线粒体糖尿病
diabetesexogenous insulin autoimmune syndromeinsulin autoantibodymitochondrial gene mutationsmitochondrial diabetes
《解放军医学院学报》 2024 (001)
34-38 / 5
评论